Annals of Nuclear Medicine

, Volume 17, Issue 2, pp 153–157 | Cite as

Tc-99m-tetrofosmin scintigraphy in a primary giant cell tumor of bone with pulmonary metastases

  • Zeynep Yapar
  • Mustafa Kibar
  • Serdar Ozbarlas
  • Berksoy Sahin
  • Aysun Uguz
  • Gulfiliz Gonlusen
  • Mehmet Emin Inal
Case Reports
  • 29 Downloads

Abstract

Giant cell tumor (GCT) is usually considered to be a benign entity. In rare cases, pulmonary metastases can be observed. This report documents the99mTc-tetrofosmin scan findings of a conventional GCT of the femur and developed pulmonary nodules. The lung lesions were felt to be an example of benign metastases. According to our review, this is the first case in the literature demonstrating tetrofosmin accumulation in a GCT of bone and its pulmonary metastases.

Key words

Tc-99m-tetrofosmin giant cell tumor of bone pulmonary metastases 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Liu P, Tao S, Xia K. Giant-cell tumor of bone: a review of diagnosis and treatment of 105 cases.Zhonghua Zhong Liu Za Zhi 1997; 19(4): 313–315.PubMedGoogle Scholar
  2. 2.
    Tubbs WS, Brown LR, Beabout JW, Rock MG, Unni KK. Benign giant-cell tumor of bone with pulmonary metastases: clinical findings and radiologic appearance of metastases in 13 cases.AJR Am J Roentgenol 1992; 158 (2): 331–334.PubMedGoogle Scholar
  3. 3.
    Feigenberg SJ, Marcus RB, Zlotecki RA Scarborough MT, Enneking WF. Whole-lung radiotherapy for giant cell tumors of bone with pulmonary metastases.Clinical Orthopaedics and Related Research, Lippincott Williams & Wilkins 2002; 401: 202–208.CrossRefGoogle Scholar
  4. 4.
    Kay RM, Eckardt JJ, Seeger LL, Mirra JM, Hak DJ. Pulmonary metastasis of benign giant cell tumor of bone. Six histologically confirmed cases, including one of spontaneous regression.Clin Orthop 1994; 302: 219–230.PubMedGoogle Scholar
  5. 5.
    Takechi E, Ito S, Taguchi K. Follow-up study of giant cell tumor of bone.Acta Med Okayama 1982; 36 (5): 349–360.PubMedGoogle Scholar
  6. 6.
    Tyler W, Barrett T, Frassica F, McCarthy E. Skin metastasis from conventional giant cell tumor of bone: conceptual significance.Skeletal Radiol 2002; 31 (3): 166–170.PubMedCrossRefGoogle Scholar
  7. 7.
    Boomsma MM, Niemeyer MG, van der Wall EE, et al. Tc-99m tetrofosmin myocardial SPECT perfusion imaging: comparison of rest-stress and stress-rest protocols.Int J Card Imaging 1998; 14 (2): 105–111.PubMedCrossRefGoogle Scholar
  8. 8.
    Grouters RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT.J Nucl Cardiol 2000; 7 (4): 333–341.CrossRefGoogle Scholar
  9. 9.
    Kostakoglu L, Uysal U, Özyar E, et al. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon emission tomography in the detection of nasopharyngeal carcinoma.Eur J Nucl Med 1997; 24: 621–628.PubMedGoogle Scholar
  10. 10.
    Obwegeser R, Berghammer P, Rodrigues M, et al. A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.Eur J Nucl Med 1999; 26: 1553–1559.PubMedCrossRefGoogle Scholar
  11. 11.
    Takekawa H, Shinano H, Tsukamoto E, Koseki Y, Ikeno T, Miller F, et al. Technetium-99m-tetrofosmin imaging of lung cancer: relationship with histopathology.Ann Nucl Med 1999; 13 (2): 71–75.PubMedCrossRefGoogle Scholar
  12. 12.
    Hashimoto T, Takahashi K, Goto M, et al. Detection of malignant thymoma in primary tumour and metastatic lesions using99mTc-tetrofosmin scintigraphy.Radiot Med 2001; 19 (3): 169–172.Google Scholar
  13. 13.
    Adalet I, Kocak M, Oguz H, et al. Determination of medullary thyroid carcinoma metastases by201Tl,99mTc(V)DMSA,99mTc-MIBI and99mTc-tetrofosmin.Nucl Med Commun 1999; 20 (4): 353–359.PubMedCrossRefGoogle Scholar
  14. 14.
    Soderlund V, Jonsson C, Bauer HCF, et al. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.J Nucl Med 1997; 38: 682–686.PubMedGoogle Scholar
  15. 15.
    Soricelli A, Cuocolo A, Varrone A, et al. Technetium-99m-tetrofosmin uptake in brain tumours by SPECT: comparison with thallium-201 imaging.J Nucl Med 1998; 39: 802–806.PubMedGoogle Scholar
  16. 16.
    Picci P, Ferrari S, Bacci G, Gherlizzoni F. Treatment recommendations for osteosarcoma and adult soft tissue sarcomas.Drugs 1994; 47 (1): 82–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.J Nucl Med 1996; 37: 1551–1556.PubMedGoogle Scholar
  18. 18.
    De Jong M, Bernard BF, Breeman WAP, et al. Comparison of uptake of99mTc-MIBI,99mTc-tetrofosmin and99mTc-Q12 into human breast cancer cell lines.Eur J Nucl Med 1996; 23: 1361–1366.PubMedCrossRefGoogle Scholar
  19. 19.
    Arbab AS, Koizumi K, Toyama K, Araki T. Ion transport systems in the uptake of99mTc-tetrofosmin,99mTc-MIBI and201Tl in a tumor cell line.Nucl Med Commun 1997; 18: 235–240.PubMedCrossRefGoogle Scholar
  20. 20.
    Rodrigues M, Chehne F, Kalinowska W, et al. Comparative99mTc-MIBI,99mTc-tetrofosmin and99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.Eur J Nucl Med 2000; 27: 1839–1843.CrossRefGoogle Scholar
  21. 21.
    Söderlund V, Jonsson C, Bauer HCF, et al. Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas.J Nucl Med 1997; 38: 682–686.PubMedGoogle Scholar
  22. 22.
    Yapar Z, Kibar M, Ozbarlas S, Uguz A, Zorludemir S. The value of Tc-99m-tetrofosmin scintigraphy as an indicator of malignancy amongst bone and soft-tissue tumors.Eur J Nucl Med 2001; 28 (8): 1236.Google Scholar
  23. 23.
    Cheng JC, Johnston JO. Giant cell tumor of bone Prognosis and treatment of pulmonary metastases.Clin Orthop 1997; 338: 205–214.PubMedCrossRefGoogle Scholar
  24. 24.
    van Hoeven KH, Kellogg K, Bavaria JE. Pulmonary metastasis from histologically benign giant cell tumor of bone. Report of a case diagnosed by fine needle aspiration cytology.Acta Cytol 1994; 38 (3): 410–414.PubMedGoogle Scholar
  25. 25.
    Obata H, Kido M, Kim ST, Nagata N, Yoshimatsu H. Multiple pulmonary metastasis from histologically benign giant cell tumor of the right radial olecranon.Nihon Kyobu Shikkan Gakkai Zasshi 1991; 29 (8): 1070–1074.PubMedGoogle Scholar
  26. 26.
    Mori Y, Tsuchiya H, Karita M, Nonomura A, Nojima T, Tomita K. Malignant transformation of a giant cell tumor 25 years after initial treatment.Clin Orthop 2000; 381: 185–191.PubMedCrossRefGoogle Scholar
  27. 27.
    Marui T, Yamamoto T, Yoshihara H, Kurusaka M, Mizuno K, Akamatsu T.De novo malignant transformation of giant cell tumor of bone.Skeletal Radiol 2001; 30 (2): 104–108.PubMedCrossRefGoogle Scholar
  28. 28.
    Merad M, Mesurolle B, Guinebretiere JM, Lecesne A, Missenard G, Vanel D. Recurrence of a primary malignant giant cell tumor of bone 14 years after initial surgery.Eur Radiol 2001; 11 (8): 1483–1486.PubMedCrossRefGoogle Scholar
  29. 29.
    Mondal A, Kundu R, Chatterjee J. Primary malignant giant cell tumour of bone_— a study of two cases with short review.Indian J Pathol Microbiol 2000; 43 (4): 403–407.PubMedGoogle Scholar
  30. 30.
    Levine E, De Smet AA, Neff JR, Martin NL. Scintigraphic evaluation of giant cell tumor of bone.AJR Am J Roentgenol 1984; 143 (2): 343–348.PubMedGoogle Scholar
  31. 31.
    Kobayashi H, Sakahara H, Hosono M, Shirato M, Konishi J, Kotoura Y, et al. Scintigraphic evaluation of tenosynovial giant-cell tumor using technetium-99m(V)-dimercapto-succinic acid.J Nucl Med 1993; 34 (10): 1745–1747.PubMedGoogle Scholar

Copyright information

© Springer 2003

Authors and Affiliations

  • Zeynep Yapar
    • 1
  • Mustafa Kibar
    • 1
  • Serdar Ozbarlas
    • 2
  • Berksoy Sahin
    • 3
  • Aysun Uguz
    • 4
  • Gulfiliz Gonlusen
    • 4
  • Mehmet Emin Inal
    • 5
  1. 1.Department of Nuclear MedicineÇukurova University Medical SchoolAdanaTurkey
  2. 2.Department of OrthopedicsÇukurova University Medical SchoolAdanaTurkey
  3. 3.Department of OncologyÇukurova University Medical SchoolAdanaTurkey
  4. 4.Department of PathologyÇukurova University Medical SchoolAdanaTurkey
  5. 5.Department of RadiologyÇukurova University Medical SchoolAdanaTurkey

Personalised recommendations